BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world’s first and only multi-center ...

Ekos, a Bothell medical device maker whose catheter-based ultrasound devices are used to break up blood clots in legs, has been acquired by British pharmaceutical company BTG for $180 million. The ...

BOTHELL – Ekos Corp., which has spent more than a decade inventing ultrasound-enhanced catheters that can quickly break up blood clots, is ready to sell the device to doctors around the world. The ...

Please provide your email address to receive an email when new articles are posted on . HOLLYWOOD, Fla. — In patients with acute submassive pulmonary embolism, treatment with tissue plasminogen ...

Please provide your email address to receive an email when new articles are posted on . Catheter-directed thrombolysis was linked to less major bleeding than mechanical thrombectomy in patients with ...

BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation, a BTG International group company (BTG plc (LSE:BTG)), announced the publication of results of the SEATTLE II trial in the JACC: Cardiovascular ...

BOTHELL, Wash.-- EKOS Corporation announced today the EKOS EkoSonic® Endovascular System is the first endovascular device approved for the treatment of pulmonary embolism (PE). The EkoSonic® System, ...

IRMO, SC (WIS) - A 36-year-old Irmo woman started having shortness of breath. That developed into chest pains and dizziness. A CT scan revealed a life-threatening health situation - a blood clot.

Randomized Controlled Multi-Center Trial Demonstrates Reduced Treatment Time and Drug Dose with EKOS vs. Catheter-Directed Thrombolysis in Peripheral Arterial Occlusions EKOS Corporation, a privately ...